Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference

Core Insights - Regulus Therapeutics Inc. is set to present at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, at 8:30 a.m. ET, highlighting its focus on innovative medicines targeting microRNAs [1] - A replay of the presentation will be available on the company's investor relations website for 90 days following the event [2] - Regulus Therapeutics specializes in the discovery and development of medicines targeting microRNAs, supported by a strong intellectual property portfolio in this field [3] Company Overview - Regulus Therapeutics Inc. is a biopharmaceutical company listed on Nasdaq (RGLS) and is headquartered in San Diego, California [3] - The company has developed a pipeline of oligonucleotide drugs, leveraging its expertise in microRNA research [3]